DoE-Based Solid Self-microemulsifying Drug Delivery System (S-SMEDDS) Approach for Improving the Dissolution Properties of Raltegravir Potassium

Sourabhkumar Jain,Kiran Dudhat,M. M. Soniwala,Nirav Kotadiya,Dhavalkumar Mori
DOI: https://doi.org/10.1007/s12247-022-09621-5
2022-02-14
Journal of Pharmaceutical Innovation
Abstract:ObjectiveRaltegravir potassium (RP) exhibits very low water solubility over the range of physiological pH (1.2, 4.5, and 6.8), which leads to poor dissolution properties and ultimately high intra- and inter-patient variabilities. The present research work aimed to prepare RP-loaded solid self-microemulsifying drug delivery system (S-SMEDDS) of RP to improve its dissolution characteristics.MethodsBased on results of drug solubilization capacity and emulsification efficiency, labrasol, Tween-20, and PEG-400 were selected as oil, emulsifier, and co-emulsifier, respectively. A ternary phase diagram was generated to identify the proportion of compositions that, upon mixing, formed a clear and transparent microemulsion. In the present investigation, simplex lattice design was used to explore the effect of variations in the composition of excipients on significant formulation characteristics.ResultThe regression analysis suggested a significant effect of the change in the proportion of composition on selected response variables. Optimized SMEDDS formulation was mixed with selected carriers in a mortar to prepare S-SMEDDS. The results of DSC and powder X-ray diffraction studies indicated the complete transformation of the crystalline drug into the amorphous or molecular level dispersed form when neusiline US2 was used as a carrier.ConclusionThe results of in vitro dissolution studies proved significant improvement in the dissolution properties from the S-SMEDDS formulation compared to the pure drug (f2 < 50).Graphical Abstract
pharmacology & pharmacy
What problem does this paper attempt to address?